Company Filing History:
Years Active: 2013
Title: Sasmita Triparthy: Innovator in Cancer Treatment
Introduction
Sasmita Triparthy is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of medical science, particularly in the development of novel compounds for treating cancer and viral diseases. Her innovative work has the potential to impact the lives of many patients suffering from these conditions.
Latest Patents
Sasmita Triparthy holds a patent for her invention titled "Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases." This patent encompasses novel Dipyrrole Compounds, compositions that include these compounds, and methods for treating or preventing cancer and neoplastic disorders. The invention focuses on administering Dipyrrole Compounds to inhibit the growth of cancer cells, treat viral infections, and provide screening assays for compounds that can be used in combination with Dipyrrole Compounds.
Career Highlights
Sasmita Triparthy is associated with Gemin X Pharmaceuticals Canada Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on improving therapeutic options for patients.
Collaborations
Sasmita collaborates with talented professionals in her field, including Giorgio Attardo and Elise Rioux. Their combined expertise contributes to the success of their projects and enhances the research environment at Gemin X Pharmaceuticals.
Conclusion
Sasmita Triparthy's contributions to the field of cancer treatment through her innovative patents and collaborative efforts highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes in the fight against cancer and viral diseases.